MedTrace Logo

Refinement of Suicide Risk Management Intervention

NCT04888845 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-05-12

No results posted yet for this study

Summary

Participants will be randomly assigned to 1 of the 4 interventions using a sequential stratified randomization procedure. We will use sex (M, F) and history of suicide attempts (never, 1, and multiple) as our randomization strata. Participants will be assessed before and after the intervention to study the potential effects of each approach on suicide-related clinical outcomes.

Conditions

  • Structured Interview
  • Narrative Assessment
  • Safety Plan
  • Crisis Response Plan

Interventions

BEHAVIORAL

Safety Plan

The safety plan is a written, prioritized list of coping strategies and resources for reducing suicide risk.

BEHAVIORAL

Crisis Response Plan

Crisis response planning intervention teaches a range of coping strategies and provides support that can reduce suicide attempts and ideation.

BEHAVIORAL

Structured interview

In the structured interview approach, clinicians ask a series of predetermined questions and/or assess a specified set of risk and protective factors, typically using a checklist-based approach.

BEHAVIORAL

Narrative Assessment

In the narrative assessment approach, clinicians ask patients to "tell the story" of their suicidal crisis.

Sponsors & Collaborators

Principal Investigators

  • Monika Lohani, PhD · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-22
Primary Completion
2028-07-30
Completion
2028-07-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04888845 on ClinicalTrials.gov